Verrica Pharmaceuticals (VRCA) Q3 2026 Earnings

6AugConfirmed
Q3 2025
Q4 2025
Q2 2026
Q3 2026
-0.9
-0.59
-0.29
0.02

Details

Expected EPS
-0.3875
Actual EPS
-0.62
Surprise EPS
-0.23
Surprise Percent
+60%

Description

Verrica Pharmaceuticals (VRCA) has reported earnings of -0.62 per share for Q3 2026.

0 Comments

Share your thoughts